Fiduciary Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839K | Sell |
12,000
-250
| -2% | -$17.5K | 0.01% | 440 |
|
|
2025
Q1 | $900K | Buy |
12,250
+1,027
| +9% | +$75.5K | 0.01% | 409 |
|
|
2024
Q4 | $735K | Buy |
11,223
+4,039
| +56% | +$265K | 0.01% | 411 |
|
|
2024
Q3 | $560K | Buy |
7,184
+113
| +2% | +$8.8K | 0.01% | 458 |
|
|
2024
Q2 | $551K | Buy |
7,071
+577
| +9% | +$45K | 0.01% | 437 |
|
|
2024
Q1 | $440K | Sell |
6,494
-218
| -3% | -$14.8K | 0.01% | 476 |
|
|
2023
Q4 | $452K | Buy |
6,712
+448
| +7% | +$30.2K | 0.01% | 463 |
|
|
2023
Q3 | $424K | Buy |
6,264
+9
| +0.1% | +$609 | 0.01% | 466 |
|
|
2023
Q2 | $448K | Buy |
6,255
+10
| +0.2% | +$716 | 0.01% | 465 |
|
|
2023
Q1 | $433K | Sell |
6,245
-2,053
| -25% | -$142K | 0.01% | 469 |
|
|
2022
Q4 | $563K | Buy |
8,298
+115
| +1% | +$7.8K | 0.01% | 433 |
|
|
2022
Q3 | $449K | Sell |
8,183
-1,378
| -14% | -$75.6K | 0.01% | 444 |
|
|
2022
Q2 | $632K | Sell |
9,561
-55
| -0.6% | -$3.64K | 0.01% | 408 |
|
|
2022
Q1 | $638K | Buy |
9,616
+116
| +1% | +$7.7K | 0.01% | 430 |
|
|
2021
Q4 | $554K | Sell |
9,500
-106
| -1% | -$6.18K | 0.01% | 458 |
|
|
2021
Q3 | $577K | Buy |
9,606
+1,325
| +16% | +$79.6K | 0.01% | 445 |
|
|
2021
Q2 | $496K | Buy |
8,281
+512
| +7% | +$30.7K | 0.01% | 470 |
|
|
2021
Q1 | $387K | Hold |
7,769
| – | – | 0.01% | 493 |
|
|
2020
Q4 | $389K | Buy |
+7,769
| New | +$389K | 0.01% | 466 |
|